Q-AID brings together Europe’s leading industrial, clinical, and academic partners to transform medical imaging.
Our mission is to integrate quantum-enhanced metabolic imaging with advanced AI tools, opening new possibilities for diagnosis and treatment. To achieve this, Q-AID leverages hyperpolarized MRI (HP-MRI), a quantum technology that enables the visualization of metabolic processes in real time.
Q-AID addresses key unmet needs in diseases such as cancer, Alzheimer’s disease, and multiple sclerosis by revealing metabolic shifts that signal the early onset of illness. This enables earlier, more accurate diagnosis and more effective treatment monitoring.
As part of the European Commission’s Quantum Europe Strategy, Q-AID contributes to positioning Europe as a global leader in quantum innovation.
The Q-AID Consortium
The Q-AID Consortium is a world-class team of experts from academia, leading clinical centers, and industry from across Europe. Our partners bring diverse expertise in quantum physics, AI, medical imaging, and clinical medicine to the project.
Our Approach
We aim to shape the future of medical imaging and diagnostics by focusing on:
-
Building a Scalable Platform: Creating an integrated system that combines HP-MRI with AI-based imaging analytics.
-
Preclinical Validation: Validating our HP-MRI agents and AI tools in preclinical models of cancer (including ovarian and breast cancer) and neurodegenerative diseases (such as Alzheimer’s disease and multiple sclerosis).
-
Clinical Translation: Conducting small-scale clinical studies (20–70 patients), including:
-
Evaluating early treatment response in Triple-Negative Breast Cancer (TNBC), HER2+ breast cancer, and ovarian cancer during neoadjuvant chemotherapy (NACT)
-
Measuring neuroinflammation and metabolic dysfunction in multiple sclerosis and Alzheimer’s disease to improve early diagnosis and treatment monitoring.
-
-
EU-Wide Adoption: Establishing the regulatory, clinical, and data frameworks required to enable large-scale adoption of this diagnostic platform across Europe.
Events & News
EQTC 2025
November 10-12, 2025
Meet the Q-AID team at the European Quantum Technologies Conference (EQTC 2025) in Copenhagen from November 10-12, 2025. It is Europe’s flagship quantum conference and a key opportunity to learn more about our work.
Contact Us
Interested in learning more about Q-AID?